Tonix Pharmaceuticals Holding (TNXP) Profit After Tax (2023 - 2025)
Historic Profit After Tax for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$31.8 million.
- Tonix Pharmaceuticals Holding's Profit After Tax fell 10102.29% to -$31.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$97.7 million, marking a year-over-year increase of 3109.61%. This contributed to the annual value of -$136.7 million for FY2024, which is 1718.1% down from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Profit After Tax stood at -$31.8 million for Q3 2025, which was down 10102.29% from -$27.4 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Profit After Tax registered a high of -$15.8 million during Q3 2024, and its lowest value of -$77.3 million during Q2 2024.
- For the 3-year period, Tonix Pharmaceuticals Holding's Profit After Tax averaged around -$29.7 million, with its median value being -$27.3 million (2023).
- Over the last 5 years, Tonix Pharmaceuticals Holding's Profit After Tax had its largest YoY gain of 6462.14% in 2025, and its largest YoY loss of 10102.29% in 2025.
- Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Profit After Tax stood at -$27.3 million in 2023, then grew by 17.72% to -$22.5 million in 2024, then crashed by 41.62% to -$31.8 million in 2025.
- Its Profit After Tax stands at -$31.8 million for Q3 2025, versus -$27.4 million for Q2 2025 and -$16.1 million for Q1 2025.